Short Interest in Novozymes A/S (OTCMKTS:NVZMY) Decreases By 67.7%

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) was the recipient of a large drop in short interest during the month of January. As of January 15th, there was short interest totaling 27,389 shares, a drop of 67.7% from the December 31st total of 84,786 shares. Based on an average daily volume of 75,516 shares, the days-to-cover ratio is currently 0.4 days. Based on an average daily volume of 75,516 shares, the days-to-cover ratio is currently 0.4 days.

Novozymes A/S Stock Down 3.5%

Shares of NVZMY stock opened at $62.23 on Thursday. The stock’s 50-day simple moving average is $63.19 and its 200-day simple moving average is $63.64. The firm has a market capitalization of $30.21 billion, a PE ratio of 36.82, a P/E/G ratio of 1.19 and a beta of 1.09. Novozymes A/S has a fifty-two week low of $53.95 and a fifty-two week high of $75.99. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.00 and a current ratio of 1.61.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

See Also

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.